RecruitingNCT06658496

PDA for Kidneys Study

Development of a Novel Kidney-focused Approach to Treatment of a Patent Ductus Arteriosus (PDA) in Vulnerable Preterm Neonates - A Pilot Study


Sponsor

University of Wisconsin, Madison

Enrollment

45 participants

Start Date

Dec 19, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.


Eligibility

Min Age: 1 MinuteMax Age: 7 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Near Infrared Spectroscopy for people with congenital heart disease and patent ductus arteriosus. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENear Infrared Spectroscopy

Application of regional NIRS sensors to brain and kidney sites in the first 72 hours after birth to monitor regional tissue oxygenation.


Locations(1)

Meriter Hospital, Inc.

Madison, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06658496


Related Trials